Deutsche Bank Ag\ Mirati Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $5.32 Million - $7.9 Million	-126,585 Reduced 52.19%	115,976 $6.81 Million
Q3 2023 Nov 09, 2023	BUY	$27.8 - $45.35 $195,489 - $318,901	7,032 Added 2.99%	242,561 $10.6 Million
Q2 2023 Aug 14, 2023	SELL	$36.13 - $49.49 $120,168 - $164,603	-3,326 Reduced 1.39%	235,529 $8.51 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $421,452 - $625,834	11,534 Added 5.07%	238,855 $8.88 Million
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $1.02 Million - $2.43 Million	24,688 Added 12.18%	227,321 $10.3 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $1.79 Million - $2.61 Million	-30,119 Reduced 12.94%	202,633 $14.2 Million
Q2 2022 Aug 11, 2022	BUY	$39.16 - $88.71 $369,239 - $836,446	9,429 Added 4.22%	232,752 $15.6 Million
Q1 2022 May 13, 2022	BUY	$75.82 - $150.97 $301,991 - $601,313	3,983 Added 1.82%	223,323 $18.4 Million
Q4 2021 Feb 11, 2022	SELL	$132.01 - $190.29 $44.9 Million - $64.8 Million	-340,348 Reduced 60.81%	219,340 $32.2 Million
Q3 2021 Nov 04, 2021	SELL	$132.13 - $177.45 $177,582 - $238,492	-1,344 Reduced 0.24%	559,688 $99 Million
Q2 2021 Aug 11, 2021	BUY	$144.0 - $179.73 $48.1 Million - $60 Million	333,765 Added 146.86%	561,032 $90.6 Million
Q1 2021 May 13, 2021	SELL	$158.92 - $221.61 $4.99 Million - $6.95 Million	-31,381 Reduced 12.13%	227,267 $38.9 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $22 Million - $32.6 Million	135,642 Added 110.27%	258,648 $56.8 Million
Q3 2020 Nov 12, 2020	SELL	$113.26 - $167.27 $4.54 Million - $6.71 Million	-40,112 Reduced 24.59%	123,006 $20.4 Million
Q2 2020 Aug 13, 2020	SELL	$72.01 - $120.39 $4.87 Million - $8.13 Million	-67,569 Reduced 29.29%	163,118 $18.6 Million
Q1 2020 May 14, 2020	SELL	$69.78 - $116.21 $1.02 Million - $1.71 Million	-14,676 Reduced 5.98%	230,687 $17.7 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $11.4 Million - $20.8 Million	161,127 Added 191.28%	245,363 $31.6 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $18.5 Million - $26.1 Million	-237,971 Reduced 73.86%	84,236 $6.56 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $14.9 Million - $26.2 Million	250,442 Added 348.98%	322,207 $33.2 Million
Q1 2019 May 15, 2019	SELL	$43.65 - $78.95 $755,494 - $1.37 Million	-17,308 Reduced 19.43%	71,765 $5.26 Million
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $4.98 Million - $7.39 Million	-155,774 Reduced 63.62%	89,073 $3.78 Million
Q3 2018 Dec 21, 2021	BUY	$47.1 - $62.7 $3.5 Million - $4.66 Million	74,388 Added 43.64%	244,847 $11.5 Million
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $3.07 Million - $4.08 Million	65,133 Added 61.84%	170,459 $8.03 Million
Q2 2018 Apr 21, 2020	BUY	$26.05 - $52.4 $172,763 - $347,516	6,632 Added 6.72%	105,326 $5.19 Million
Q2 2018 Aug 14, 2018	SELL	$26.05 - $52.4 $1.07 Million - $2.15 Million	-41,076 Reduced 29.39%	98,694 $4.86 Million
Q1 2018 Oct 18, 2019	BUY	$17.2 - $34.95 $600,847 - $1.22 Million	34,933 Added 33.32%	139,770 $4.29 Million
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $1.77 Million - $3.61 Million	103,180 Added 6226.92%	104,837 $3.22 Million
Q4 2017 Feb 14, 2018	SELL	$12.65 - $19.0 $188,333 - $282,872	-14,888 Reduced 89.98%	1,657 $30,000
Q3 2017 Nov 14, 2017	BUY	$4.7 - $11.7 $77,761 - $193,576	16,545	16,545 $193,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account